Elan, Milkhaus deal

Milkhaus received a milestone payment from ELN consisting of cash and an equity investment triggered by ELN's decision to pursue development of Milkhaus' technology to treat Alzheimer's disease, which ELN licensed last year (see BioCentury, Jan. 18, 1999). ...